Subscribe To
Kalvista pharmaceuticals to present data at the 2023 annual scientific meeting of the american college of allergy, asthma & immunology
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a ...
November 2, 2023, 6:30 am
Molecular partners to present initial data from ongoing phase 1/2a trial of mp0533 for patients with relapsed/refractory aml and aml/mds at the 65th ash annual meeting and exposition
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (...
November 2, 2023, 2:00 am
Corvus pharmaceuticals announces publication of preclinical data demonstrating potential of itk inhibition with soquelitinib as a novel approach to t cell-mediated inflammatory and immune diseases
Data demonstrated soquelitinib was active in six inflammatory/immune disease models and provides rationale for development in a range of additional Th...
November 1, 2023, 11:31 pm
Olema oncology to participate in upcoming investor conferences in november
SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a ...
November 1, 2023, 8:27 pm
Hillevax to present at upcoming investor conferences
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceut...
November 1, 2023, 4:48 pm
Cellectis to report third quarter 2023 financial results on november 6, 2023
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a ...
November 1, 2023, 4:30 pm
Olema oncology to participate in upcoming investor conferences in november
SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a ...
November 1, 2023, 4:27 pm
Gracell biotechnologies to participate in four upcoming investor conferences
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDA...
November 1, 2023, 4:00 pm
Processa pharmaceuticals announces formation of oncology advisory board with renowned key opinion leaders
Company To Leverage World-Class Oncology Advisory Board in the Design of Oncology Trial Protocols, Including the Anticipated Phase 2 Trial for NGC-Cap...
November 1, 2023, 12:15 pm
Masonic cancer center, university of minnesota to present data in poster presentation human data readout for phase 1 study to evaluate hcw9218 in solid tumors at sitc 38th annual meeting
HCW9218 is the lead product candidate of HCW Biologics Inc. MIRAMAR, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or...
November 1, 2023, 11:30 am
Sensei biotherapeutics appoints stephanie krebs, ms, mba, as chief business officer
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stag...
November 1, 2023, 11:30 am
Clearside biomedical completes recruitment in odyssey phase 2b clinical trial of cls-ax in wet amd
– Successful Completion of Recruitment Driven by Strong clinical Site Participation and Investigator ...
November 1, 2023, 11:05 am
Celcuity to present at upcoming stifel and jefferies investor conferences
MINNEAPOLIS, Nov. 01, 2023 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechn...
November 1, 2023, 11:05 am
Springworks therapeutics announces presentation of additional data from phase 3 defi trial of nirogacestat in adults with desmoid tumors at the 2023 ctos annual meeting
– Nirogacestat Treatment Demonstrated Rapid and Sustained Improvements in Functional Status Compared to Placebo Across Multiple Assessment Tools –...
November 1, 2023, 10:30 am
Anaptys announces participation in november investor conferences
SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechn...
November 1, 2023, 9:15 am
Zymeworks announces participation in upcoming investor conferences
VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical...
November 1, 2023, 8:30 am
Aptevo to present at bio-europe conference
SEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage ...
November 1, 2023, 7:45 am
Celcuity to present at upcoming stifel and jefferies investor conferences
MINNEAPOLIS, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechno...
November 1, 2023, 7:05 am
Atea pharmaceuticals to host third quarter 2023 financial results conference call on november 8, 2023
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical...
November 1, 2023, 7:00 am
Affimed to participate in upcoming investor conferences
MANNHEIM, Germany, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a ...
November 1, 2023, 6:30 am